Qube Research & Technologies (QRT)
SUPN icon

Qube Research & Technologies (QRT)’s Supernus Pharmaceuticals SUPN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.9M Buy
922,166
+423,968
+85% +$20.4M 0.04% 552
2026
Q1 		$25.8M Buy
498,198
+186,360
+60% +$9.49M 0.03% 735
2025
Q4 		$15.5M Buy
311,838
+187,715
+151% +$9.13M 0.02% 1058
2025
Q3 		$5.93M Sell
124,123
-105,587
-46% -$4.25M 0.01% 1655
2025
Q2 		$7.24M Buy
229,710
+131,632
+134% +$4.22M 0.01% 1485
2025
Q1 		$3.21M Buy
98,078
+32,968
+51% +$1.17M ﹤0.01% 1754
2024
Q4 		$2.35M Sell
65,110
-35,854
-36% -$1.26M ﹤0.01% 1813
2024
Q3 		$3.15M Sell
100,964
-59,208
-37% -$1.85M ﹤0.01% 1585
2024
Q2 		$4.28M Buy
160,172
+150,569
+1,568% +$4.36M 0.01% 1330
2024
Q1 		$328K Sell
9,603
-84,722
-90% -$2.52M ﹤0.01% 2766
2023
Q4 		$2.73M Buy
+94,325
New +$2.5M 0.01% 1370
2023
Q3 		– Sell
-59,318
Closed -$1.78M – 4324
2023
Q2 		$1.78M Buy
59,318
+12,992
+28% +$455K 0.01% 1089
2023
Q1 		$1.68M Buy
46,326
+14,151
+44% +$544K 0.01% 1081
2022
Q4 		$1.15M Buy
32,175
+16,806
+109% +$584K 0.01% 1165
2022
Q3 		$520K Buy
+15,369
New +$500K ﹤0.01% 1452
2022
Q1 		– Sell
-51,750
Closed -$1.51M – 2986
2021
Q4 		$1.51M Buy
+51,750
New +$1.57M 0.01% 963
2020
Q3 		– Sell
-10,474
Closed -$249K – 2091
2020
Q2 		$249K Sell
10,474
-225
-2% -$4.97K ﹤0.01% 1364
2020
Q1 		$192K Sell
10,699
-24,563
-70% -$516K 0.01% 882
2019
Q4 		$836K Buy
+35,262
New +$856K 0.03% 690

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SUPN Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Supernus Pharmaceuticals (SUPN) stake by 85% in Q2 2026, buying an estimated $20.4M and bringing the position to 922,166 shares worth $42.9M. The position accounts for 0.04% of the portfolio, ranked #552.

Qube Research & Technologies (QRT) first reported a position in SUPN in Q4 2019 and has held it in 19 quarters since. 335 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Qube Research & Technologies (QRT) held 922,166 shares of Supernus Pharmaceuticals worth $42.9M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 423,968 Supernus Pharmaceuticals shares in Q2 2026, an estimated $20.4M.
  • Supernus Pharmaceuticals made up 0.04% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #552 holding.
  • Qube Research & Technologies (QRT) first reported a position in Supernus Pharmaceuticals in Q4 2019 and has held it in 19 quarters since.
  • 335 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.